Quarterly report · Q3
3154.TEDINET S100TEKT
Period2023-07-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥193.1bn | 2023-07-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥239.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥181.4bn | 2022-07-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2023-07-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥2.4bn | 2022-07-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2023-07-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2022-07-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.0bn | 2023-07-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.9bn | 2022-07-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2023-07-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.1bn | 2023-07-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥1.8bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥115.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥97.5bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥105.8bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥95.4bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥78.9bn | at 2023-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥19.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥18.6bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥18.4bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥52.27 | 2023-07-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.23 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.32 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.92 | 2022-07-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.72 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥52.08 | 2023-07-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥68.09 | 2022-07-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥81.67 | 2022-07-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 17.1% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.1% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2024-03-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2024-03-31 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2024-03-31 | −¥6.2bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue | 2023-07-01 → 2024-03-31 | ¥188.8bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2023-07-01 → 2024-03-31 | ¥188.8bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-07-01 → 2024-03-31 | ¥2m |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2023-07-01 → 2024-03-31 | ¥7.5bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2023-07-01 → 2024-03-31 | ¥4.4bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2023-07-01 → 2024-03-31 | ¥4.4bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2023-07-01 → 2024-03-31 | ¥336m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2024-03-31 | ¥193.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2024-03-31 | ¥193.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2024-03-31 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2024-03-31 | ¥7.8bn |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-03-31 | −¥176,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-03-31 | −¥176,000 |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-03-31 | −¥5.5bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥177.2bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥177.2bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥176,000 |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥7.5bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥315m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2023-03-31 | ¥181.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2023-03-31 | ¥181.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥176,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2023-03-31 | ¥7.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 385
| Item | Context | Value | Unit |
|---|---|---|---|
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)メディアスホールディングス㈱ | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都千代田区有楽町一丁目２番２号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding guarantee obligations (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentQuarterInstant | Text · Plus | |
| Notes when there is significant seasonal fluctuation in sales or operating expenses (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes business combinations quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |